Theratechnologies on the Rise: Exploring Strategic Acquisition Opportunities Amidst Market Buzz
Published / Modified Apr 11 2025
CSIMarket Team / CSIMarket.com

On April 11, 2025, Theratechnologies Inc.
(NASDAQ: THTX), a Montreal-based biopharmaceutical company specializing in innovative therapies for unmet medical needs, made
More Merger and Acquisition News |
Merger and Acquisition
Better Choice Company Announces Closing of the SRx Health Merger, Name/Symbol Change and Completes $8.8 Million Private Placement Priced Above Last Market Closing Price,April 25, 2025 |
Merger and Acquisition
Crane Harbor Acquisition Corp. Takes Flight with $200 Million IPO: Opportunities AheadApril 24, 2025 |
Merger and Acquisition
S&P Global Expands Data Services with ORBCOMM Acquisition Amid Stock SetbackApril 24, 2025 |
Previous News
?March 2025 Consumer Price Index: Mixed Signals as U.S. Prices Drop, Yet Core Inflation Persists?
,
Crinetics Pharmaceuticals Strengthens Talent Acquisition with Strategic Inducement Grants
Endeavour Silvers Q1 Production Soars Amidst Financial Turmoil: A Double-Edged Sword for Investors
Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer
South Bow Corp. Navigates Pipeline Incident and Investor Concerns Amid Q2 Share Price Decline
Previous News
?March 2025 Consumer Price Index: Mixed Signals as U.S. Prices Drop, Yet Core Inflation Persists?
,
Crinetics Pharmaceuticals Strengthens Talent Acquisition with Strategic Inducement Grants
Endeavour Silvers Q1 Production Soars Amidst Financial Turmoil: A Double-Edged Sword for Investors
Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer
South Bow Corp. Navigates Pipeline Incident and Investor Concerns Amid Q2 Share Price Decline